PROHANCE sol inj 8.5 mmol/17ml ser préremp 5 pce

7680525991132 CH-52599 V08CA04 14.02.0.

Active substances:

No images available

Details

Product number
5259901
CPT
-
Packaging group
5 x 17
Unit
ml
Composition
gadoteridolum 279.3 mg corresp. 0.5 mmol, calteridolum calcicum, trometamolum, acidum hydrochloridum aut natrii hydroxidum corresp. natrium max. 5.75 µg, aqua ad iniectabile ad solutionem pro 1 ml.

Articles (1)

ProHance 0.5 mmol/ml, soluzione iniettabile (siringa di iniezione preriempita)
soluzione iniettabile (siringa di iniezione preriempita)
5 x 17
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
gadoteridolum
279.3 MG Substance Wirkstoff (Principe actif)
calteridolum calcicum
- Substance HNIDK
trometamolum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
natrium
- Substance HBESI
aqua ad iniectabile
- Substance HNIDK

Authorization holder

Bracco Suisse SA

6814 Cadempino

Authorization information

Swissmedic authorization number
52599
Drug name
ProHance 0.5 mmol/ml, soluzione iniettabile (siringa di iniezione preriempita)
Galenic form
INLFS
ATC Code
V08CA04
Authorization status
Z
Dispensation category
B
First authorization
15/12/2000
Authorization expiration date
31/12/9999
IT number
14.02.0.
Domain
Human medicine

Packaging details

Description (FR)
PROHANCE sol inj 8.5 mmol/17ml ser préremp 5 pce
Description (DE)
PROHANCE Inj Lös 8.5 mmol/17ml Fertigspr 5 Stk
Market launch
15/12/2000
Narcotic (BTM)
No

Other packaging sizes

PROHANCE sol inj 5 mmol/10ml ser préremp
1 x 10 ML
View
PROHANCE sol inj 8.5 mmol/17ml ser préremp
1 x 17 ML
View
Buy us a coffee Explore the data